Publicaciones en las que colabora con JOAQUÍN MARÍA CAMPOS ROSA (124)

2023

  1. Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

    Molecules (Basel, Switzerland), Vol. 28, Núm. 3

  2. Preclinical evaluation of bozepinib in bladder cancer cell lines: modulation of the NPP1 enzyme

    Purinergic Signalling

2022

  1. Identification of Potential Insect Growth Inhibitor against Aedes aegypti: A Bioinformatics Approach

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. Design, synthesis, HER2 inhibition and anticancer evaluation of new substituted 1,5-dihydro-4,1-benzoxazepines

    Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, Núm. 1, pp. 1553-1563

  2. Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: Preclinical evaluation in glioblastoma

    Nanomedicine, Vol. 16, Núm. 23, pp. 2095-2115

  3. New insights into cytotoxic mechanisms of bozepinib against glioblastoma

    European Journal of Pharmaceutical Sciences, Vol. 162

2020

  1. Identification of potential COX-2 inhibitors for the treatment of inflammatory diseases using molecular modeling approaches

    Molecules, Vol. 25, Núm. 18

2019

  1. NMR studies of new heterocycles tethered to purine moieties with anticancer activity

    Magnetic Resonance in Chemistry

  2. Purine derivatives with heterocyclic moieties and related analogs as new antitumor agents

    Future Medicinal Chemistry, Vol. 11, Núm. 2, pp. 83-95

2018

  1. Enhancement of tumor cell death by combining gef gene mediated therapy and new 1,4-benzoxazepin-2,6-dichloropurine derivatives in breast cancer cells

    Frontiers in Pharmacology, Vol. 9, Núm. JUL

  2. The teaching team of experienced and beginner professors contributes to the continuous improvement of the teaching in the University of Granada

    Edulearn 18. 10th International Conference on Education and New Learning Technology: (Palma, 2nd-4th of July, 2018). Conference proceedings

2017

  1. 1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds

    Future Medicinal Chemistry, Vol. 9, Núm. 11, pp. 1129-1140

  2. Antitumoral activity of 1,2-diaminocyclohexane derivatives in breast, colon and skin human cancer cells

    Future Medicinal Chemistry, Vol. 9, Núm. 3, pp. 293-302

  3. Synthesis of 1,4-benzoxathiin-9H-purine derivatives as antiproliferative agents

    Targets in Heterocyclic Systems, Vol. 21, pp. 372-388

2016

  1. 1H and 13C NMR spectral data of p-nitrobenzenesulfonamides and dansylsulfonamides derived from N-alkylated o-(Purinemethyl)anilines

    Magnetic Resonance in Chemistry

  2. Inhibitors of cancer stem cells

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 16, Núm. 10, pp. 1230-1239

  3. The use of wiki to promote students’ learning in higher education (Degree in Pharmacy)

    International Journal of Educational Technology in Higher Education, Núm. 13

2015

  1. Cancer stem cells: The new objective for the eradication of tumours

    Horizons in Cancer Research (Nova Science Publishers, Inc.), pp. 41-81

  2. Imidazoles and benzimidazoles as tubulin-modulators for anti-cancer therapy

    Current Medicinal Chemistry, Vol. 22, Núm. 11, pp. 1312-1323

  3. P-Nitrobenzenesulfonamides and their fluorescent dansylsulfonamides derived from N-alkylated o-(purine-methyl)anilines as novel antitumour agents

    RSC Advances, Vol. 5, Núm. 93, pp. 76615-76619